Acquired copy number amplification at the <i>MYC</i> enhancer in human B‐precursor acute lymphoblastic leukemia cell lines-Reference-Cited by-同舟云学术

Acquired copy number amplification at the MYC enhancer in human B‐precursor acute lymphoblastic leukemia cell lines

Published:2024-06-26 Issue:9 Volume:115 Page:3196-3199
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Watanabe Atsushi¹²³^ORCID,Wang Lu²,Tan Tze King²,Urayama Kevin Y.⁴⁵,Kizuki Toshihiko¹,Komatsu Chiaki¹,Kagami Keiko¹,Shinohara Tamao¹,Kasai Shin¹,Tamai Minori¹,Harama Daisuke¹,Akahane Koshi¹^ORCID,Goi Kumiko¹,Goto Hiroaki⁶^ORCID,Satou Kazuhito⁷,Kaname Tadashi⁷^ORCID,Sanda Takaomi²⁸,Inukai Takeshi¹

Affiliation:

1. Department of Pediatrics School of Medicine, University of Yamanashi Yamanashi Japan

2. Cancer Science Institute of Singapore, National University of Singapore Singapore City Singapore

3. Department of Pediatrics Yamanashi Prefectural Central Hospital Kofu Japan

4. Department of Social Medicine National Center for Child Health and Development Tokyo Japan

5. Graduate School of Public Health St. Luke's International University Tokyo Japan

6. Division of Hematology/Oncology Kanagawa Children's Medical Center Yokohama Japan

7. Department of Genome Medicine National Center for Child Health and Development Tokyo Japan

8. Department of Medicine Yong Loo Lin School of Medicine, National University of Singapore Singapore City Singapore

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.16260

Reference9 articles.

1. The chromatin accessibility landscape of primary human cancers

2. Super-enhancer function and its application in cancer targeted therapy

3. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

4. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells

5. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia